In humans, Kapoor et al. (2013) identified increased urinary levels of hippuric acid in patients with RA and PsA after treatment with infliximab, an anti-tumor necrosis factor (anti-TNF) agent (Kapoor et al., 2013). This evidence concerns the gene TNF and rheumatoid arthritis.